# FDA 483 - Imran S. Khawaja, M.D. - May 06, 2025

Source: https://www.globalkeysolutions.net/records/483/imran-s-khawaja-md/85598509-f788-448d-8050-56d7cc1669d3

> FDA 483 for Imran S. Khawaja, M.D. on May 06, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Imran S. Khawaja, M.D.
- Inspection Date: 2025-05-06
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: Imran S. Khawaja, M.D., a clinical investigator in Fort Worth, TX, was cited for failing to conduct an investigation in accordance with the investigational plan. The inspection revealed multiple instances where subjects were enrolled in studies without meeting eligibility criteria, including missing required laboratory tests and being on exclusionary medications. This indicates significant deviations from study protocols.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/travis-m-beard/a89f6d0b-dc5b-4adc-84f5-36e04b00fc2d)

Company: https://www.globalkeysolutions.net/companies/imran-s-khawaja-md/dc9b2ff3-c377-49a3-93fb-5d14cf0e9161

Office: https://www.globalkeysolutions.net/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9